Advicenne Is A Specialty Pharmaceutical Company Based In Parisfocused On Developing Innovative Treatments For Rare Renal Diseasesfounded In 2007 And Listed On Euronext Growth Since 2022Advicenne Aims To Improve The Lives Of Patients With Limited Therapeutic Options Through Its Expertise In Reformulation And Drug Delivery The Company Is Dedicated To The Research And Development Of Treatments For Rare Renal Conditionswith A Commitment To Making These Therapies Available For Both Children And Adultsadvicenne S Product Portfolio Includes Sibnayala Approved For The Treatment Of Distal Renal Tubular Acidosisand Adv7103Which Is In Late Stage Development For Cystinuria And Drtathe Company Markets And Distributes Its Products Internationallyensuring Access For Patients Globallywith A Strong Focus On Addressing Unmet Medical Needsadvicenne Is Committed To Enhancing The Quality Of Life For Patients Suffering From Rare Renal Diseases
